Serum lipoproteins, apolipoproteins and very low density lipoprotein subfractions during 6-month fibrate treatment in primary hypertriglyceridaemia-Reference-Cited by-同舟云学术

Serum lipoproteins, apolipoproteins and very low density lipoprotein subfractions during 6-month fibrate treatment in primary hypertriglyceridaemia

Published:1990-11 Issue:5 Volume:228 Page:425-430
ISSN:0954-6820
Container-title:Journal of Internal Medicine
language:en
Short-container-title:

Author:

PAUCIULLO P.,MAROTTA G.,RUBBA P.,CORTESE C.,CARUSO M. G.,GNASSO A.,FISCHETTI A.,MOTTI C.,MANCINI M.

Publisher

Wiley

Subject

Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2796.1990.tb00258.x/fullpdf

Reference28 articles.

1. Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study;Manninen;J Am Med Assoc,1988

2. Long term use of gemfibrozil (Lopid) in the treatment of dyslipidemia;Lewis;Angiology,1982

3. Hyperlipoproteinemia, atherosclerosis and gemfibrozil;Nash;Angiology,1982

4. Effect of gemfibrozil on lipoprotein concentrations in different types of hyperlipoproteinaemia;Olsson;Proc R Soc Med,1976

5. Gemfibrozil effect on serum lipids, lipoproteins, post-heparin plasma lipase activities and glucose tolerance in primary hypertriglyceridaemia;Nikkilä;Proc R Soc Med,1976

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in diagnosis and potential therapeutic options for familial chylomicronemia syndrome;Expert Opinion on Orphan Drugs;2018-01-02

2. Hepatic PPARs: Their Role in Liver Physiology, Fibrosis and Treatment;Current Medicinal Chemistry;2013-07-01

3. Drug Therapy and Follow-Up;Atherosclerosis Disease Management;2010-11-11

4. Is There a Role for Fibrates in the Management of Dyslipidemia in the Metabolic Syndrome?;Arteriosclerosis, Thrombosis, and Vascular Biology;2008-01

5. Fibrates in Combination With Statins in the Management of Dyslipidemia;The Journal of Clinical Hypertension;2006-01